Canton Strategic Holdings Stock Price, News & Analysis
Company Description
Canton Strategic Holdings (NASDAQ: CNTN) is a publicly traded biotechnology company in the Pharmaceutical Preparations sector. The company has a market capitalization of $192.6M, ranking #4,571 among all listed U.S. companies by market cap.
CNTN stock has declined 39.7% over the past year. Shares last traded at $2.98.
On a trailing twelve-month basis, Canton Strategic Holdings reported net income of -$35.9M and diluted earnings per share of $-1.12.
This page provides a comprehensive overview of CNTN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Canton Strategic Holdings (CNTN) stock last traded at $2.98, down 9.71% from the previous close. Over the past 12 months, the stock has lost 39.7%. At a market capitalization of $192.6M, CNTN is classified as a micro-cap stock with approximately 56.7M shares outstanding.
Latest News
Canton Strategic Holdings has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include earnings. View all CNTN news →
SEC Filings
Canton Strategic Holdings has filed 5 recent SEC filings, including 3 Form 8-K, 1 Form 10-K, 1 Form 424B5. The most recent filing was submitted on March 31, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CNTN SEC filings →
Financial Highlights
operating income reached -$20.1M, and net income was -$35.9M. Diluted earnings per share stood at $-1.12. The company generated -$16.1M in operating cash flow. With a current ratio of 5.29, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Days to Cover History
CNTN Company Profile & Sector Positioning
Canton Strategic Holdings (CNTN) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ. In monthly performance, the stock ranks #4,195 among all tracked companies.